[Choline deficiency studies - see full reference list] 73-75
GLP-1 Medications: Whats Actually Happening
Signs it might be legitimate remodelling: Mild, diffuse changes in the first 2-4 weeks
Impact of Biofilms on Chronic Infections and Medical Challenges
4d), and four of five substrates with the highest luminescence values had enrichment scores above 2.0 (CLSPN = 3.526, EIF3J = 2.219, MCM5 = 2.125 and TF65 = 4.204)
Who Should Consider It Anyone with elevated toxin burden (heavy metal exposure, mycotoxin illness, chemical sensitivities) requiring enhanced Phase II detox capacity Individuals undergoing structured detoxification protocols where adequate GSH conjugation capacity is critical Those with chronic illness, autoimmune conditions, or persistent inflammation associated with oxidative stress and GSH depletion Biohackers focused on mitochondrial health, longevity, and cellular redox optimisation High-performance athletes experiencing high oxidative stress from training load Anyone with a history of significant pharmaceutical exposure (statins, acetaminophen, and many other drugs deplete hepatic GSH) Ready to upgrade your antioxidant foundation